Clinical and Psychological Correlates of Two Domains of Hopelessness in Schizophrenia by Lysaker, Paul H. et al.
JRRD Volume 45, Number 6, 2008Pages 911–920
Journal of Rehabil itation Research & DevelopmentClinical and psychological correlates of two domains of hopelessness in 
schizophrenia
Paul H. Lysaker, PhD;1–2* Michelle P. Salyers, PhD;3–6 Jack Tsai, MS;1,6 Linda Yorkman Spurrier, MSN, RN;1 
Louanne W. Davis, PsyD1–2
1Richard L. Roudebush Department of Veterans Affairs (VA) Medical Center (VAMC), Indianapolis, IN; 2Indiana Uni-
versity (IU) School of Medicine, Indianapolis, IN; 3VA Health Services Research and Development Center on Imple-
menting Evidence-Based Practice, Richard L. Roudebush VAMC, Indianapolis, IN; 4IU Center for Health Services and 
Outcomes Research, Regenstrief Institute, Inc, Indianapolis, IN; 5ACT Center of Indiana, Indianapolis, IN; 
6Department of Psychology, IU-Purdue University Indianapolis, Indianapolis, IN
Abstract—Hopelessness is a widely observed barrier to recov-
ery from schizophrenia spectrum disorders. Yet little is known
about how clinical, social, and psychological factors independ-
ently affect hope. Additionally, the relationships that exist
between these factors and different kinds of hope are unclear.
To explore both issues, we correlated two aspects of hope,
expectations of the future and agency, with stigma, clinical
symptoms, anxiety, and coping preferences in 143 persons with
a schizophrenia spectrum disorder. Multiple regressions
revealed that hope for the future was predicted by lesser aliena-
tion, lesser preference for ignoring stressors, and lesser emo-
tional discomfort and negative symptoms, accounting for 43%
of the variance. A greater sense of agency was linked to lesser
endorsement of mental illness stereotypes, fewer negative
symptoms, lesser social phobia, and lesser preference for
ignoring stressors, accounting for 44% of the variance. Impli-
cations for research and interventions are discussed.
Key words: agency, anxiety, coping, hope, negative symp-
toms, positive symptoms, recovery, rehabilitation, schizophre-
nia, social phobia, stigma.
INTRODUCTION
Hope has been identified as a key factor in recovery
from mental illness [1–3]. Yet multiple reports have docu-
mented that persons with schizophrenia commonly expe-
rience potent feelings of hopelessness [4–10]. They may
anticipate that their needs will not be met in the future
and/or have come to believe that nothing is to be gained
by continuing to pursue their goals [11–12]. They may
expect rejection by others and may have a pervasive sense
that there is little point in persisting in the face of chal-
lenges [13–14]. These beliefs may occur as isolated
thoughts or as part of a larger personal narrative in which
the present and future are linked by themes of predestined
ruin and resignation [15–16]. Beyond being a matter of
subjective distress, hopelessness in persons with schizo-
phrenia has been linked to persistent social and vocational
dysfunction [11,17–21].
Abbreviations: BHS = Beck Hopelessness Scale, ISMIS =
Internalized Stigma of Mental Illness Scale, MAQ = Multidi-
mensional Anxiety Questionnaire, PANSS = Positive and Neg-
ative Syndrome Scale, SCID = Structured Clinical Interview
for the Diagnostic Statistical Manual IV, VAMC = Department
of Veterans Affairs medical center, WCQ = Ways of Coping
Questionnaire.
*Address all correspondence to Paul H. Lysaker, PhD;
Roudebush VAMC–Psychiatry, 1481 West 10th Street,
Indianapolis, IN 46202; 317-988-2546; fax: 317-554-0056.
Email: plysaker@iupui.edu, paul.lysaker@med.va.gov
DOI: 10.1682/JRRD.2007.07.0108911
912
JRRD, Volume 45, Number 6, 2008To date, the research on the roots of hopelessness has
consistently suggested that hopelessness may be influ-
enced by an array of social, clinical, and psychological
factors. Examining social causes of hopelessness, studies
have suggested that hopelessness may result from stigma
or pervasive stereotypic beliefs about severe mental ill-
ness [14,22–23]. As persons encounter and accept
stigma, the possibility of future fulfillment may seem
increasingly remote. At the clinical level, hope has been
suggested to be influenced by positive and negative
symptoms and depression [24–28]. Experiencing symp-
toms has been suggested to be naturally demoralizing and
leads to fewer positive expectations for the future. At the
psychological level, lack of hope has been linked with a
generally avoidant coping style and a vulnerability to
feeling anxious when facing social situations or other
stressors [26,29–30]. Implied here is that as persons
unsuccessfully cope with stressors, they may begin to
anticipate failure, increasingly fear embarrassment, and
see fewer reasons to persevere.
Although this literature highlights several barriers to
hope in schizophrenia, at least two important issues
remain unanswered. First, are social, clinical, and psy-
chological factors independently related to hope? Do, for
instance, stigma, coping preference, and depressed mood
each uniquely contribute to the loss of hope or is there
merely a general association between these phenomena?
Answers to these questions may have clinical and theo-
retical import by pointing to discrete chains of cognition
and behavior that culminate in hopelessness and that
could represent independent targets for intervention. To
date, at least one study has suggested that depression,
stigma, and overall symptomatology independently con-
tribute to hopelessness [31], but further examination is
needed to clarify whether these contributions are inde-
pendent of one another.
A second issue involves the question of whether dif-
ferent kinds of hope are related in a similar or dissimilar
manner to social, clinical, and psychological factors.
While hope is often considered a singular phenomenon, it
is composed of numerous semi-independent domains or
dimensions [26,32–33]. Seen through the lens of hope
theory, believing that one is on the path to meeting
desired goals is not necessarily the same thing as believ-
ing that one’s actions will directly lead to a desired out-
come [34]. As a practical example, to have hope of
receiving a good work evaluation from a supervisor is not
necessarily the same thing as to have hope that one can
persist at work despite criticism from one’s supervisor.
Theoretically then, one could have one form of hope but
lack the other, and perhaps, the absence of different forms
of hope are linked with different outcomes. Evidence that
relatively independent domains of hope exist includes
findings that changes in expectations of the future and
agency are linked with different variables in psychother-
apy among persons without psychosis [35]. Literature
suggesting that this issue is particularly relevant for per-
sons with schizophrenia includes findings that many with
schizophrenia have unique difficulties situating them-
selves as active agents within their own lives [36–37] and
seeing promise in their future [10–11]. In schizophrenia,
hope for a good outcome and hoping to persist have also
been linked with different rehabilitation outcomes [17].
In the current study, we have therefore examined the
relative associations of these two components of hope—
expectations of the future and agency—with multiple
clinical, social, and psychological factors. The factors we
selected were three forms of clinical symptoms: positive,
negative, and depressive symptoms; three dimensions of
stigma: discrimination experiences, alienation, and stereo-
type endorsement; preference for two forms of avoidant
coping: ignoring and resigning; and three dimensions of
anxiety: physiological-panic, social phobia, and general
worries and fears. We chose these variables given their
associations with hope in prior studies and also because
intuitively we reasoned that symptoms, stigma, coping,
and anxiety might be semi-independently linked to hope.
Imaginable, for instance, is that the correlation that stigma
has with hope might be partially unrelated to the correla-
tion that negative symptoms, avoidant coping, or social
anxiety have with hope. While we considered our analy-
ses to be largely exploratory, we did make three initial sets
of predictions. First, we predicted that both domains of
hope would be more strongly linked to stigma than other
clinical or psychological factors. We reasoned that of all
the constructs measured, stigma might be the most demor-
alizing given its direct impact on a person’s sense of his or
her chances of having a fulfilling life [14,23]. Second, we
predicted that the two different domains of hope would be
related to different clinical symptoms. Here we antici-
pated that positive and negative symptoms would be more
closely linked to lower levels of agency, since these symp-
toms can be closely related to the experience of one’s own
life as beyond one’s control (e.g., as in persecutory delu-
sions of lack of affect or volition). We anticipated
that future expectations would be more closely linked to
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Third, we predicted that stigma, symptoms, coping, and
anxiety would be independently linked to hope. Here we
reasoned that more profound levels of hopelessness might
result from the additive effects of all these factors. In
other words, while the experience of stigma should result
in some degree of hopelessness, stigma coupled with
more severe symptoms, anxiety, and an avoidant coping
style would result in even higher levels of hopelessness.
METHODS
Participants
We recruited 143 participants with diagnoses of
schizophrenia (n = 88) or schizoaffective disorder (n =
55), confirmed by the Structured Clinical Interview for
the Diagnostic Statistical Manual IV (SCID) [38], from
the outpatient psychiatry clinic of a Department of Veter-
ans Affairs medical center (VAMC) (n = 104) or a com-
munity mental health center (n = 39) for one of two
studies: the correlates of anxiety in schizophrenia or the
effects of cognitive therapy on rehabilitation outcome.
All participants were in a stable or postacute phase of
their disorder, as defined by participation in outpatient
treatment with no hospitalizations or changes in housing
or psychotropic medication within the last month. Exclu-
sion criteria for this study included evidence of organic
brain syndrome or mental retardation in a participant’s
chart or during an interview. On average (mean ± stand-
ard deviation), participants were 46.77 ± 9.62 years old;
had 12.60 ± 2.05 years of education; and had 12.76 ±
14.94 psychiatric hospitalizations, with the first occur-
ring at age 26.12 ± 9.89. Sixty-two were Caucasian
(43.0%), seventy-eight African American (54.5%), two
Latino (1.0%), and one Native American (0.5%). One
hundred and twenty-four (92.0%) were male, and nine-
teen were female (8.0%).
Instruments
Positive and Negative Syndrome Scale
The Positive and Negative Syndrome Scale (PANSS)
is a 30-item rating scale completed by clinically trained
research staff after a chart review and semistructured inter-
view [39]. For this study, we used factor-analytically
derived positive, negative, and emotional discomfort com-
ponents of the PANSS [40]. The emotional discomfort
component is an index of distress and includes items that
assess depressed mood, anxiety, guilt, and the active
avoidance of others. Evidence supporting the use of factor-
analytic solutions for the PANSS has been reported by
numerous other investigators [41]. Interrater reliability as
assessed for raters in this study found good to excellent
intraclass correlations on all scale scores, with intraclass
correlations ranging from 0.80 to 0.93. To reduce the over-
all number of correlations produced in this study, we did
not examine the cognitive or excitement components
because of a lack of predictions regarding the association
of these factors with hope.
Internalized Stigma of Mental Illness Scale
The Internalized Stigma of Mental Illness Scale
(ISMIS) is a 29-item questionnaire that assesses subjec-
tive experience of stigma [42–43]. It presents participants
with first-person statements related to having a mental
illness and asks them to rate on a 4-point Likert scale
how much they agree or disagree with the statements.
Items are summed to provide the following subscales:
alienation, which reflects feeling devalued as a member
of society; stereotype endorsement, which reflects agree-
ment with negative stereotypes of mental illness; dis-
crimination experience, which reflects current
mistreatment attributed to the biases of others; and social
withdrawal, which reflects avoidance of others because
of mental illness. An additional fifth score, stigma resis-
tance, asks about participants’ perceived ability to deflect
stigma. Subscale scores are calculated as averages, with
higher scores suggesting graver experiences of stigma.
Evidence of acceptable internal consistency, test-retest
reliability, and factorial and convergent validity has been
reported and includes links with morale and well-being
[42–43]. The instrument was presented to participants in
its written form, with research assistants available to
assist if participants were confused about the meaning of
any item. To reduce the overall number of correlations
that were produced, we considered the first three stigma
subscales only, given these subscales seemed most con-
ceptually relevant for the construct of hope.
Multidimensional Anxiety Questionnaire
The Multidimensional Anxiety Questionnaire
(MAQ) is a 40-item self-report questionnaire that taps
multiple domains of the experience of anxiety [44]. For
this study, we were interested in three of the four sub-
scales: physiological-panic, which assesses physiological
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phobia, which assesses worries about social embarrass-
ment and social avoidance; and worry-fears, which
assesses general experiences of worry and fearfulness in
daily life. Reynolds presents evidence of acceptable
internal consistency and test-retest reliability from both a
general psychiatric sample and a community sample and
factorial validity from a combined psychiatric and com-
munity sample [44]. The fourth subscale, negative affec-
tivity, was not considered in order to reduce the overall
number of correlations produced and because items in the
subscale often involve expectations of the future and,
thus, are not entirely conceptually distinct from the hope
constructs being measured.
Beck Hopelessness Scale
The Beck Hopelessness Scale (BHS) is a question-
naire that asks participants to endorse statements as true
or false as applied to them [32]. In this study, we used
two scale scores developed by the scales’ authors: expec-
tations of the future, which taps beliefs about how much
success versus frustration lies ahead in the future (e.g.,
“Things just won’t work out the way I want them to.”),
and motivational hope, which taps expectations of
whether one will make an effort to influence one’s life
(e.g., “I might as well give up because I can’t make
things better for myself.”). We considered the construct
of motivational hope as equivalent to agency because it
essentially involves a sense that the person can meaning-
fully affect his or her future and, thus, we refer to this
scale as measuring agency throughout this article. The
BHS has been used successfully with a wide range of
psychiatric, medical, and community populations [45–
46]. Scales of the BHS include items that reflect both
hope and hopelessness and were scored such that higher
scores reflect greater levels of hope.
Ways of Coping Questionnaire
The Ways of Coping Questionnaire (WCQ) is a self-
report instrument that asks participants to recall a recent
stressor and then rate how often they used 66 different
behaviors to cope with that particular stressor [47].
Because the factor structure of the scale may not accu-
rately reflect coping behaviors used by individuals with
chronic psychiatric illness [48], we used a rational scor-
ing system developed to be sensitive to coping difficul-
ties particular to severe mental illness [49]. This scoring
scheme yields scores for six modes of coping: ignoring,
resigning, acting, considering, positively reappraising,
and self-soothing. To reduce the overall number of corre-
lations produced, we considered only the two scales most
closely linked to avoidance of problem solving: ignoring
and resigning. Ignoring refers to putting the stressor out
of one’s mind, or choosing to “not think” about it.
Resigning refers to a choice to not act because it is per-
ceived that nothing is to be done. In one study that com-
pared results derived from the original scoring system
with our revised scoring scheme across two previous
samples, the rationally devised scales had better internal
consistency and predicted psychosocial function prospec-
tively [49]. In calculating scores, we used relative scores,
as we have elsewhere [49]. We obtained these scores for
each scale by dividing the mean score for that scale by
the mean score for the total test. This method has the
advantage of pointing to participants’ relative prefer-
ences and corrects somewhat for response bias.
Procedures
The research review committees of Indiana University
and the Roudebush VAMC approved all procedures. After
participants gave informed consent, a clinical psychologist
used the SCID to determine diagnoses. After the SCID,
participants in both studies were administered the PANSS
interview, ISMIS, WCQ, MAQ, and BHS. A research
assistant was available to assist participants if they had
difficulties reading or understanding the questionnaires.
PANSS ratings were performed blind to responses to the
ISMIS, WCQ, MAQ, and BHS. Trained research assis-
tants with a minimum of a bachelor’s degree in a psychol-
ogy-related field conducted the PANSS interviews. We did
not perform interventions in either study before obtaining
the baseline information analyzed here.
Analyses
Analyses were planned in four stages. First, as noted
in the “Instruments” section, we selected a priori the sub-
scales of each instrument most relevant to coping to
reduce the overall number of correlations produced. This
resulted in the selection of 11 from a possible 20 total
variables. Second, we examined whether hope scores
were linked to demographic variables. Third, we exam-
ined correlations between the two hope scores and the 11
predictor variables previously described. Given the num-
ber of correlations used [22], we reduced alpha to 0.01
and chose to use two-tailed tests despite unidirectional
hypotheses. Fourth, we performed two stepwise multiple
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correlations were allowed to enter to predict each of the
hope scores.
RESULTS
Hope scores were unrelated to age, sex, education, or
diagnosis (schizophrenia vs schizoaffective disorder).
Both BHS hope scores were significantly correlated with
each other (r = 0.68, p < 0.001). Mean scores for the two
hope subscales and the other selected measures are
reported in Table 1.
To determine whether hope domains were linked with
stigma, coping, anxiety, symptoms, and neurocognition,
we calculated Pearson correlations. As shown in Table 2,
both aspects of hope were significantly correlated with all
measures. Finally, to determine whether these correlates
were uniquely linked with both domains of hope, we con-
ducted two stepwise multiple regressions, allowing all the
variables to enter into the equation. As summarized in
Table 3, these analyses revealed that greater hope for the
future was predicted by lesser levels of alienation, lesser
coping preference for ignoring, lesser emotional discom-
fort, and lesser negative symptoms, accounting for
43 percent of the variance. Greater agency was linked to
lesser stereotyped beliefs about mental illness, lesser neg-
ative symptoms, lesser social phobia, and lesser coping
preference for ignoring, accounting for 44 percent of the
variance.
DISCUSSION
Results are largely consistent with the results of pre-
vious studies of the correlates of hope [22–26,29–31].
Both the expectation of success in the future and the
expectation of being able to persist were linked to lesser
levels of stigma, fewer symptoms, lesser anxiety, and
lesser preference for avoidant forms of coping. Partially
consistent with our first prediction, several of the stigma
scores were strongly correlated with both hope dimen-
sions. When entered into a multiple regression, alienation
was the most closely linked variable to expectations of
the future and stereotyped endorsement was the most
Table 1.
Hope, neurocognition, symptoms, stigma, and coping scores in partici-
pants with schizophrenia spectrum disorder (n = 143).
Measure Mean ± Standard Deviation
BHS
Motivational Hope 5.93 ± 2.49
Expectations of the Future 2.58 ± 1.56
PANSS
Positive Component 15.80 ± 5.01
Negative Component 18.55 ± 5.23
Emotional Discomfort Component 12.77 ± 4.38
ISMIS
Alienation 2.39 ± 0.70
Stereotype Endorsement 1.97 ± 0.51
Discrimination Experience 2.41 ± 0.66
MAQ
Physiological-Panic T-Score 72.48 ± 23.46
Social Phobia T-Score 66.84 ± 16.29
Worry-Fears T-Score 76.79 ± 21.53
WCQ
Resigning 1.00 ± 0.35
Ignoring 0.86 ± 0.30
BHS = Beck Hopelessness Scale, ISMIS = Internalized Stigma of Mental Ill-
ness Scale, MAQ = Multidimensional Anxiety Questionnaire, PANSS = Posi-
tive and Negative Syndrome Scale, WCQ = Ways of Coping Questionnaire.
Table 2.
Correlations of two hope domains with neurocognition, symptoms,
stigma, and coping in participants with schizophrenia spectrum disor-
der (n = 143).
Correlate Expectations of the Future Agency
PANSS
Positive Component –0.28* –0.26*
Negative Component –0.30† –0.41†
Emotional Discomfort Component –0.46† –0.31†
ISMIS
Alienation –0.51† –0.44†
Stereotype Endorsement –0.43† –0.47†
Discrimination Experience –0.32† –0.28*
MAQ
Physiological-Panic –0.30† –0.34†
Social Phobia –0.44† –0.42†
Worry-Fears –0.37† –0.40†
WCQ
Resigning –0.32† –0.34†
Ignoring –0.33† –0.33†
*p < 0.01.
†p < 0.001.
ISMIS = Internalized Stigma of Mental Illness Scale, MAQ = Multidimen-
sional Anxiety Questionnaire, PANSS = Positive and Negative Syndrome
Scale, WCQ = Ways of Coping Questionnaire.
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with our second prediction, different clinical symptoms
had different relationships with hope. When entered into
a multiple regression, negative symptoms were more
closely linked to agency, while emotional distress was
more closely linked to expectations of the future. Positive
symptoms, however, were only modestly linked to both
hope dimensions in univariate correlations.
Our third prediction was also partially supported.
Stigma, symptoms, anxiety, and coping were all uniquely
linked in multiple regressions to agency, while stigma,
symptoms, and coping were uniquely linked to expecta-
tions of the future. Participants with greater hope for the
future tended to feel more similarities between them-
selves and others, to have a lesser preference for ignoring
in the face of stressors, and less severe emotional discom-
fort and negative symptoms. Participants who believed
they could more greatly affect their futures tended to dis-
agree with stereotyped portrayals of persons with mental
illness, have fewer negative symptoms, have a lesser fear
of social embarrassment, and have a lesser preference for
ignoring challenges.
While the cross-sectional design and exploratory
nature of this study do not allow us to directly address the
question of causality, the results could suggest several
hypotheses. Different aspects of stigma are possibly
linked to different domains of hope. A sense of oneself as
fundamentally similar to others may be necessary to sus-
tain the hope that one can attain what others can in the
future. The rejection of stereotyped beliefs about mental
illness may be necessary to see persistence in the face of
challenge as meaningful. Similarly, negative symptoms
may be a strong barrier to the experience of agency. With
decreased affect and interest, some may experience them-
selves as less than fully fledged participants in their own
lives. As noted, though, these interpretations should be
treated as speculative and rival hypotheses cannot be
ruled out. Lower levels of hope possibly make persons
more susceptible to the effects of stigma or lead to symp-
tom exacerbation. The associations noted here may also
have resulted from factors not assessed in this study. Lon-
gitudinal studies including multiple assessments of these
variables are required before we will be able to tease out
causal influences.
Regarding interventions, with replication, this study
may suggest the importance of developing and linking
services that combat stigma and address coping style,
social anxiety, depression, and negative symptoms.
Treatment that is multilayered and offers different inter-
ventions depending on the presence or absence of differ-
ent forms of hope may also be important. For instance,
persons who struggle to see themselves as able to persist
may have relatively greater needs to reject stereotypes
and cope with negative symptoms and social phobia. Per-
sons who see the future as having little promise may need
help managing depression and seeing themselves as
belonging in their communities. These possibilities are
consistent with emerging models of how psychotherapy
and rehabilitation may enhance a sense of personhood
and agency, thereby empowering persons to make health-
ier decisions about their lives [50–51].
As noted previously, several unexpected results were
found that may also suggest speculation for future study.
The relatively weak relationships between positive symp-
Table 3.
Multiple regressions predicting two hope domains (n = 143).
Hope R2 Component Contributing Factors F (df) Partial R2 Model
Expectations of the Future Alienation 25.78 (138,4)* 0.26† 0.26
Ignoring 0.07* 0.33
Emotional discomfort 0.06* 0.39
Negative symptoms 0.04‡ 0.43
Agency Stereotyped beliefs 26.97 (138,4)* 0.22† 0.22
Negative symptoms 0.09* 0.31
Social phobia 0.08* 0.40
Ignoring 0.05* 0.44
*p < 0.01.
†p < 0.001.
‡p < 0.05.
df = degrees of freedom.
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ences of hallucinations and delusions, while disruptive in
the moment, have a limited affect on persons’ expecta-
tions of their future and ability to persist over time. The
modest link between discrimination experiences and
hope may suggest that beyond encountering actual dis-
crimination, the meaning that persons assign to stigma is
what affects hope.
We should note that agency and expectations of the
future were strongly correlated and both dimensions of
hope demonstrated a pattern of similar correlations with
many other measures. Thus, how these dimensions differ
from each another and how they converge conceptually
and empirically remain unclear. Future work is needed,
including confirmatory factor analyses to empirically
demonstrate the presence of these separate factors in the
BHS and to confirm that the results of the multiple
regression analyses we have reported were based on
actual discrimination across factors.
Finally, this study had several other limitations. Par-
ticipants were predominantly male and generally in their
40s. We assessed hope by using one self-report measure.
Replication and more systematic study is needed with
samples that include more females and males in earlier
phases of illness and that incorporate multiple methods of
assessing hope from the perspective of participants, their
families, and practitioners. Additionally, this exploratory
study represents a beginning. Many possible correlates of
hope were not examined (e.g., social network) and need to
be included in future studies. Given that multiple analyses
were performed and that the observed correlations were
modest, the clinical significance of these findings remains
to be determined. Lastly, because all participants had
schizophrenia spectrum disorders, we cannot determine
whether the purported relationships are specific to schizo-
phrenia. Future studies are needed that include samples of
people who do not have schizophrenia in order to develop
insight into whether what was found here is unique among
persons who experience this illness.
CONCLUSIONS
Results suggest that the experience of stigma, nega-
tive symptoms, emotional discomfort, anxiety, and cop-
ing preferences are, to some degree, uniquely linked with
hope among participants with schizophrenia spectrum
disorders. The dimension of hope that involves anticipat-
ing that one’s goals will be attained in the future was most
closely predicted by alienation due to stigma, preference
for ignoring stressors, emotional discomfort, and negative
symptoms. The domain of hope that was linked to a sense
that one can affect one’s future was most closely linked
with the acceptance of stereotyped beliefs about mental
illness, severity of negative symptoms, degree of social
phobia, and preference for ignoring stressors.
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